Prognostic Value of Serum Soluble Programmed Death-Ligand 1 and Dynamics During Chemotherapy in Advanced Gastric Cancer Patients

Purpose The soluble form programmed death-ligand 1 (sPDL1) has immunosuppressive properties and is being studied as a candidate biomarker for immuno-oncologi drug development. We measured the serum sPDL1 at pre-and post-chemotherapy and evaluated its prognostic implication and dynamics during chemot...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer research and treatment 2021, 53(1), , pp.199-206
Hauptverfasser:	Park, Woochan, Bang, Ju-Hee, Nam, Ah-Rong, Jin, Mei Hua, Seo, Hyerim, Kim, Jae-Min, Oh, Kyoung Seok, Kim, Tae-Yong, Oh, Do-Youn
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over B7-H1 Antigen - metabolism Female Humans Life Sciences & Biomedicine Male Middle Aged Oncology Original Prognosis Progression-Free Survival Prospective Studies Science & Technology Stomach Neoplasms - drug therapy Stomach Neoplasms - mortality 의학일반
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!